Aehr Test Systems (AEHR) Peer Comparison
$83.53
$-6.93
(-7.66%)
As on 28-Aug-2026 13:37EDT
Market cap
$3,318 Mln
Revenue (TTM)
$51 Mln
P/E Ratio
--
P/B Ratio
15.1
Div. Yield
0 %
Edit
| Aehr Test Systems (AEHR) | Lam Research Corp (LRCX) | KLA-Tencor Corporation (KLAC) | Synaptics Incorporated $0.001 Par Value (SYNA) | ScanSource (SCSC) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
3,318 | 392,915 | 240,392 | 3,819 | 1,105 |
Revenue ($ Mln) |
50 | 23,233 | 13,579 | 1,197 | 3,226 |
Net Profit ($ Mln) |
-7.13 | 7,265.40 | 4,830.77 | -490.80 | 78.87 |
Net Margin (%) |
-14.00 | 31.27 | 35.57 | -41.00 | 2.44 |
RoE (%) |
-4.16 | 65.07 | 87.50 | -42.23 | 8.68 |
Price to Earnings |
-- | 54.04 | 50.27 | -- | 15.48 |
Price-To-Book |
15.11 | 31.16 | 37.86 | 4.11 | 1.26 |
Income Statement ($ Mln)
| Aehr Test Systems (AEHR) | Lam Research Corp (LRCX) | KLA-Tencor Corporation (KLAC) | Synaptics Incorporated $0.001 Par Value (SYNA) | ScanSource (SCSC) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
50.00 | 23,232.69 | 13,579.48 | 1,197.20 | 3,226.06 |
|
Cost of Revenue
|
32.35 | 11,507.38 | 5,255.06 | 661.80 | 2,788.71 |
|
Gross Profit
|
17.65 | 11,725.31 | 8,324.42 | 535.40 | 437.36 |
|
Operating Expenses
|
31.80 | 3,525.51 | 2,663.64 | 602.50 | 338.73 |
|
Operating Profit (EBIT)
|
-14.15 | 8,199.80 | 5,660.78 | -67.10 | 98.63 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
-11.74 | 8,262.47 | 5,605.93 | -79.40 | 103.74 |
|
Provision for Tax
|
-4.61 | 997.08 | 775.15 | 411.40 | 24.87 |
|
Profit after Tax (Net Income)
|
-7.13 | 7,265.40 | 4,830.77 | -490.80 | 78.87 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | -- | -- | -- | -- |
Liabilities ($ Mln)
| Aehr Test Systems (AEHR) | Lam Research Corp (LRCX) | KLA-Tencor Corporation (KLAC) | Synaptics Incorporated $0.001 Par Value (SYNA) | ScanSource (SCSC) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
219.51 | 12,470.92 | 6,349.82 | 929.50 | 910.79 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
9.33 | 5,121.57 | 7,296.79 | 471.20 | 162.50 |
|
Current Liabilities
|
17.86 | 5,937.25 | 4,304.93 | 701.30 | 859.14 |
|
Total Liabilities
|
246.69 | 23,529.74 | 17,951.54 | 2,102.00 | 1,932.43 |
Assets ($ Mln)
| Aehr Test Systems (AEHR) | Lam Research Corp (LRCX) | KLA-Tencor Corporation (KLAC) | Synaptics Incorporated $0.001 Par Value (SYNA) | ScanSource (SCSC) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
62.25 | 7,919.04 | 5,569.75 | 1,315.00 | 424.44 |
|
Current Assets
|
184.45 | 15,610.71 | 12,381.79 | 787.00 | 1,507.99 |
|
Total Assets
|
246.69 | 23,529.74 | 17,951.54 | 2,102.00 | 1,932.43 |
|
Total Debt*
|
9.88 | 4,121.57 | 6,151.71 | 837.30 | 2.87 |
|
Net Current Assets
|
166.59 | 9,673.46 | 8,076.86 | 85.70 | 648.85 |
Cashflow ($ Mln)
| Aehr Test Systems (AEHR) | Lam Research Corp (LRCX) | KLA-Tencor Corporation (KLAC) | Synaptics Incorporated $0.001 Par Value (SYNA) | ScanSource (SCSC) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-3.31 | 5,857.66 | 4,143.08 | 149.40 | 123.13 |
|
Cash Flow from Investing Activities
|
-3.87 | -922.15 | -1,190.10 | 13.00 | -27.51 |
|
Cash from Financing Activities
|
97.21 | -5,717.79 | -3,385.61 | -111.50 | -134.48 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Aehr Test Systems (AEHR) | Lam Research Corp (LRCX) | KLA-Tencor Corporation (KLAC) | Synaptics Incorporated $0.001 Par Value (SYNA) | ScanSource (SCSC) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-3.93 | 46.56 | 41.50 | -24.29 | 8.02 |
|
ROE (%)
|
-4.16 | 65.07 | 87.50 | -42.23 | 8.68 |
|
ROA (%)
|
-3.61 | 32.38 | 28.40 | -20.95 | 4.24 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-14.25 | 31.27 | 35.57 | -41.00 | 2.44 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Aehr Test Systems (AEHR) | Lam Research Corp (LRCX) | KLA-Tencor Corporation (KLAC) | Synaptics Incorporated $0.001 Par Value (SYNA) | ScanSource (SCSC) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-0.15 | 0.26 | 0.12 | 0.11 | 0.06 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-82.25 | 35.59 | 18.94 | -926.78 | 10.24 |
|
EPS Growth (%)
|
-- | 0.37 | 0.20 | -9.19 | 0.21 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Aehr Test Systems (AEHR) | Lam Research Corp (LRCX) | KLA-Tencor Corporation (KLAC) | Synaptics Incorporated $0.001 Par Value (SYNA) | ScanSource (SCSC) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | 75.22 | 82.42 | -9.85 | 14.33 |
|
Price / Book Value
|
-- | 43.82 | 62.70 | 5.20 | 1.24 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
9.07 | 62.62 | 69.35 | -95.39 | 9.47 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Aehr Test Systems (AEHR) | Lam Research Corp (LRCX) | KLA-Tencor Corporation (KLAC) | Synaptics Incorporated $0.001 Par Value (SYNA) | ScanSource (SCSC) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.05 | 0.33 | 0.97 | 0.90 | 0.00 |
|
Short term debt to equity ratio
|
0.00 | 0.01 | 0.01 | 0.47 | 0.00 |
|
Current Ratio
|
10.33 | 2.63 | 2.88 | 1.12 | 1.76 |
|
Quick Ratio
|
8.01 | 1.91 | 2.03 | 0.90 | 1.15 |
|
Interest Coverage
|
-- | 52.67 | 19.90 | -5.46 | -- |
Operating Efficiency Ratios
| Aehr Test Systems (AEHR) | Lam Research Corp (LRCX) | KLA-Tencor Corporation (KLAC) | Synaptics Incorporated $0.001 Par Value (SYNA) | ScanSource (SCSC) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
34.95 | 22.98 | 23.49 | 13.70 | 23.86 |
|
Asset Turnover
|
0.25 | 1.04 | 0.80 | 0.51 | 1.74 |
|
Receivable days
|
128.80 | 68.53 | 75.63 | 44.89 | 85.18 |
|
Inventory Days
|
470.54 | 136.23 | 238.42 | 81.65 | 65.89 |
|
Payable days
|
76.11 | 34.23 | 37.61 | 49.97 | 88.53 |
|
Cash Conversion Cycle
|
523.23 | 170.53 | 276.45 | 76.57 | 62.54 |
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
